|
RU2512743C1
|
|
Pharmaceutical compositions of ipidacrine and using them for treating and preventing solution of continuity
|
|
RU2516922C2
|
|
Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders
|
|
RU2494739C1
|
|
Pharmaceutical compositions containing ipidacrine and using them for treating disturbed potency and other forms of sexual activity
|
|
RU2503452C2
|
|
Pharmaceutical composition of docosahexanoic acid for prevention of hyperactive syndrome in children
|
|
RU2478376C1
|
|
Pharmaceutical composition based on vegetative dha for treating and preventing diseases of joints
|
|
RU2505289C2
|
|
Pharmaceutical composition of herbal docosahexaenoic acid for treating and preventing hepatic disorders
|
|
RU2505290C2
|
|
Pharmaceutical composition possessing exhibiting property of endothelial dysfunction reduction accompanying cardiovascular diseases
|
|
RU2468803C2
|
|
Use of polydatine for treating hepatic diseases and polydatine pharmaceutical composition
|
|
RU2210360C1
|
|
Psychotropic agent
|
|
RU2177783C1
|
|
Nootropic preparation
|
|
RU2181717C1
|
|
Neorotropic agent and method of its producing
|
